![Cecilia Matthews](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cecilia Matthews
Corporate Officer/Principal bij
AURINIA PHARMACEUTICALS INC.
Profiel
Cecilia Matthews is currently Vice President-Organizational Development at Aurinia Pharmaceuticals, Inc. since 2022.
Formerly, Ms. Matthews was Senior Vice President-Development Consultant at Citizens Financial Group, Inc. (Rhode Island) from 2019 to 2022 and Director-Global Human Resource Business Partner at AstraZeneca PLC from 2013 to 2019.
Ms. Matthews completed graduate studies at The New School for Social Research.
Actieve functies van Cecilia Matthews
| Bedrijven | Functie | Begin |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01-01-2022 |
Eerdere bekende functies van Cecilia Matthews
| Bedrijven | Functie | Einde |
|---|---|---|
| CITIZENS FINANCIAL GROUP, INC. | Corporate Officer/Principal | 01-01-2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-01-2019 |
Opleiding van Cecilia Matthews
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
78
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Citizens Financial Group, Inc. (Rhode Island)
 Citizens Financial Group, Inc. (Rhode Island) Major BanksFinance Operates as a bank holding company whose subsidiary provides banking services | Finance |
The New School for Social Research
 The New School for Social Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
